Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Private Equity Firm Archimed To Buy ZimVie As Antitrust Concerns Sideline Strategic Buyers

Jul 22 2025

• By Marion Webb

Novo's acquisition of Catalent was formalized at the end of 2024 (Shutterstock)

Related Content

ZimVie Wins Investigational Device Exemption For Disc Replacement Device, Plans To Begin Study

Sep 26 2023

Zimmer Biomet Spin-Off’s Share Price Plummets

Mar 07 2022

Device Week, 10 March 2022 – Femtech Attracts Investors; ZimVie Fails To Impress Wall Street

Mar 10 2022

Execs On The Move: Zimmer's Spin-Off, ZimVie, Appoints New Directors

Mar 04 2022

Zimmer Biomet’s Dental And Spine Spin-Off Will Be Called ZimVie

Sep 15 2021

Execs On The Move: Zimmer Biomet Announces ZimVie Spin-Off Roles

Sep 17 2021

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window